Stryker is a global medical technology company founded in 1941 by Dr. Homer Stryker, operating across 75 countries with $22.6 billion in annual sales as of 2024. The company focuses on three core business segments: MedSurg, Neurotechnology, and Orthopaedics, impacting more than 150 million patients annually through products and services designed to improve patient and healthcare outcomes. With a portfolio spanning surgical technologies, endoscopy systems, neurovascular devices, joint replacement systems, sports medicine solutions, acute care equipment, and healthcare communications infrastructure, Stryker maintains 14,200 patents and invested $1.5 billion in R&D in 2024.
The company's technical domains address specific clinical challenges across the surgical and interventional spectrum. In neurotechnology, this includes neurovascular devices for stroke and aneurysm treatment. The orthopaedics division develops joint replacement systems and sports medicine products for reconstructive procedures. MedSurg operations encompass surgical instrumentation, endoscopic visualization systems, and acute care technologies including patient handling and emergency medical equipment. These systems operate in demanding environments - operating rooms, catheterization labs, and acute care settings - where reliability, precision, and integration with existing hospital infrastructure are non-negotiable constraints.
What began as a small orthopedic device manufacturer has grown into what the company describes as an industry powerhouse, maintaining operations that span from product development through commercial deployment. The engineering culture emphasizes accountability and performance, with teams working alongside clinical customers to deploy solutions in real-world healthcare settings. Under CEO Kevin Lobo's leadership, the organization maintains headquarters in the United States while supporting a distributed global operation that delivers medical technology systems to healthcare facilities worldwide.